Fundraising FoxSynvitrobio, Inc.
San Leandro, US · Delaware corporation · 1 known investors
Find your way into Synvitrobio, Inc.
Sign up to see every warm intro you have to Synvitrobio, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Synvitrobio, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Revr (SynVitro Bio) designs functional proteins by combining AI models with large-scale biophysical data generated from an automated wet lab platform, using a closed-loop process to speed up protein refinement. The company operates a cloud-based, API-accessible system that expresses and functionally tests roughly 1,000 proteins per week for protein engineering applications.
Founders & leadership
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$17.6M disclosed across 1 round · 2023
▶$17.6MraisedSep 2023 · 16 investors · Other Health CareRule 506(b)
- Michael NemzekExecutive Officer, Director
- Francisco DopazoDirector
- Zachary SunExecutive Officer, Director
- Corinna ChenDirector
- Offering amount
- $17.6M
- Amount sold
- $17.6M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 11 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. ArmyArmy | Phase IISTTR | 2020 | $1000K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $252.1K |
| Department of Energy | Phase I | 2019 | $200K |
| U.S. ArmyArmy | Phase ISTTR | 2019 | $150K |
| National Science Foundation | Phase IISTTR | 2018 | $750K |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $276K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $225K |
| U.S. ArmyArmy | Phase ISTTR | 2017 | $150K |
| National Science Foundation | Phase ISTTR | 2016 | $225K |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase I | 2016 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Synvitrobio, Inc. do?
- Revr (SynVitro Bio) designs functional proteins by combining AI models with large-scale biophysical data generated from an automated wet lab platform, using a closed-loop process to speed up protein refinement. The company operates a cloud-based, API-accessible system that expresses and functionally tests roughly 1,000 proteins per week for protein engineering applications.
- Who founded Synvitrobio, Inc.?
- Synvitrobio, Inc. was founded by Zachary Sun.
- Who are Synvitrobio, Inc.'s investors?
- Synvitrobio, Inc.'s investors include Humboldt.
- How much funding has Synvitrobio, Inc. raised?
- Synvitrobio, Inc. has disclosed $17.6M raised across 1 round.
- Where is Synvitrobio, Inc. headquartered?
- Synvitrobio, Inc. is headquartered in San Leandro, US.